Article

The cytoplasmic tails of Uukuniemi Virus (Bunyaviridae) G(N) and G(C) glycoproteins are important for intracellular targeting and the budding of virus-like particles.

Ludwig Institute for Cancer Research, Stockholm Branch, Karolinska Institute, Box 240, SE-17177 Stockholm, Sweden.
Journal of Virology (Impact Factor: 5.08). 11/2007; 81(20):11381-91. DOI: 10.1128/JVI.00767-07
Source: PubMed

ABSTRACT Functional motifs within the cytoplasmic tails of the two glycoproteins G(N) and G(C) of Uukuniemi virus (UUK) (Bunyaviridae family) were identified with the help of our recently developed virus-like particle (VLP) system for UUK virus (A. K. Overby, V. Popov, E. P. Neve, and R. F. Pettersson, J. Virol. 80:10428-10435, 2006). We previously reported that information necessary for the packaging of ribonucleoproteins into VLPs is located within the G(N) cytoplasmic tail (A. K. Overby, R. F. Pettersson, and E. P. Neve, J. Virol. 81:3198-3205, 2007). The G(N) glycoprotein cytoplasmic tail specifically interacts with the ribonucleoproteins and is critical for genome packaging. In addition, two other regions in the G(N) cytoplasmic tail, encompassing residues 21 to 25 and 46 to 50, were shown to be important for particle generation and release. By the introduction of point mutations within these two regions, we demonstrate that leucines at positions 23 and 24 are crucial for the initiation of VLP budding, while leucine 46, glutamate 47, and leucine 50 are important for efficient exit from the endoplasmic reticulum and subsequent transport to the Golgi complex. We found that budding and particle generation are highly dependent on the intracellular localization of both glycoproteins. The short cytoplasmic tail of UUK G(C) contains a lysine at position -3 from the C terminus that is highly conserved among members of the Phlebovirus, Hantavirus, and Orthobunyavirus genera. Mutating this single amino acid residue in G(C) resulted in the mislocalization of not only G(C) but also G(N) to the plasma membrane, and VLP generation was compromised in cells expressing this mutant. Together, these results demonstrate that the cytoplasmic tails of both G(N) and G(C) contain specific information necessary for efficient virus particle generation.

1 Bookmark
 · 
136 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Crimean-Congo hemorrhagic fever virus (CCHFV) is a member of the genus Nairovirus within the family Bunyaviridae , and can cause severe disease in humans with a fatality rate between 5-30%. The surface glycoproteins, GN and GC , are responsible for CCHFV attachment to and entry into host cells. Additionally, they likely play critical roles in assembly and budding of virions. However, the mechanisms by which they mediate these events and their structural organization on the virion surface remain undefined. These glycoproteins are derived through endoproteolytic cleavage of a 1,684-amino-acid M RNA segment-encoded polyprotein. In order to explore the roles of GN and GC in diverse aspects of CCHFV replication, a thorough understanding of the processes that lead to their generation and subsequent interactions with other proteins is needed. In this dissertation, we have investigated the proteolytic event that defines the C terminus of the GN glycoprotein and have found that G N likely undergoes cotranslational intramembranous cleavage within its second transmembrane domain. This cleavage liberates a cell-associated nonstructural protein termed NSM , which traffics to the Golgi compartment, the site of CCHFV assembly. Sequence analysis of the transmembrane domains flanking NSM has indicated that both are candidates for signal peptidase (SPase) cleavage. Mutagenesis of the SPase cleavage site blocked N-terminal cleavage of NSM , confirming this hypothesis. Using transiently expressed M polyproteins lacking NSM , we found that gross deletion of NSM results in improper trafficking and aberrant processing of the viral glycoproteins, suggesting a possible chaperone-like role for NSM . We have also begun to probe the composition of the viral spikes by examining the oligomerization of the GC glycoprotein. We have found that GC molecules from several geographically diverse CCHFV strains existed in both monomeric and oligomeric forms, with the oligomeric form being preferentially recognized by a conformation-dependent antibody. These oligomers formed in the presence and absence of GN , and we have confirmed that the GC ectodomain is sufficient for oligomerization. Possible roles of NSM in viral assembly and GC containing oligomers in viral entry are discussed in the final chapter, along with future approaches to dissect mechanisms of entry, replication, and assembly for CCHFV.
    Dissertations available from ProQuest.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: After the unexpected emergence of BTV serotype 8 (BTV-8) in northern Europe in 2006, another arbovirus, Schmallenberg virus (SBV), emerged in Europe in 2011 causing a new economically important disease in ruminants. The virus, belonging to the Orthobunyavirus genus in the Bunyaviridae family, was first detected in Germany, in The Netherlands and in Belgium in 2011 and soon after in the United Kingdom, France, Italy, Luxembourg, Spain, Denmark and Switzerland. This review describes the current knowledge on the emergence, epidemiology, clinical signs, molecular virology and diagnosis of SBV infection.
    Veterinary Research 05/2013; 44(1):31. · 3.43 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Rift Valley fever virus (RVFV) (genus Phlebovirus, family Bunyaviridae) is an arbovirus that causes severe disease in humans and livestock in sub-Saharan African countries. Although the MP-12 strain of RVFV is a live attenuated vaccine candidate, neuroinvasiveness and neurovirulence of MP-12 in mice may be a concern when vaccinating certain individuals, especially those that are immunocompromised. We have developed a novel, single-cycle replicable MP-12 (scMP-12), which carries an L RNA, M RNA mutant encoding a mutant envelope protein lacking an endoplasmic reticulum retrieval signal and defective for membrane fusion function, and S RNA encoding N protein and green fluorescent protein. The scMP-12 underwent efficient amplification, then formed plaques and retained the introduced mutation after serial passages in a cell line stably expressing viral envelope proteins. However, inoculation of the scMP-12 into naïve cells resulted in a single round of viral replication, and production of low levels of noninfectious virus-like particles. Intracranial inoculation of scMP-12 into suckling mice did not cause clinical signs or death, a finding which demonstrated that the scMP-12 lacked neurovirulence. Mice immunized with a single dose of scMP-12 produced neutralizing antibodies, whose titers were higher than in mice immunized with replicon particles carrying L RNA and S RNA encoding N protein and green fluorescent protein. Moreover, 90% of the scMP-12-immunized mice were protected from wild-type RVFV challenge by efficiently suppressing viremia and replication of the challenge virus in the liver and the spleen. These data demonstrated that scMP-12 is a safe and immunogenic RVFV vaccine candidate.
    PLoS Neglected Tropical Diseases 03/2014; 8(3):e2746. · 4.57 Impact Factor

Full-text (2 Sources)

View
15 Downloads
Available from
May 22, 2014